Transcat (NASDAQ:TRNS – Get Free Report) issued its quarterly earnings results on Monday. The scientific and technical instruments company reported $0.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.20, Zacks reports. The firm had revenue of $66.70 million during the quarter, compared to the consensus estimate of $69.35 million. Transcat had a return on equity of 9.23% and a net margin of 5.69%. The company’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter last year, the company posted $0.38 EPS.
Transcat Stock Down 1.5 %
TRNS stock traded down $1.75 during midday trading on Wednesday, hitting $115.16. The stock had a trading volume of 8,160 shares, compared to its average volume of 42,411. The firm has a market cap of $1.05 billion, a price-to-earnings ratio of 73.53 and a beta of 0.68. The business has a 50-day moving average of $127.73 and a two-hundred day moving average of $115.77. Transcat has a 52-week low of $82.60 and a 52-week high of $147.12. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.14 and a quick ratio of 2.62.
Insider Buying and Selling
In related news, Director Charles P. Hadeed sold 1,358 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total value of $176,540.00. Following the sale, the director now directly owns 21,320 shares of the company’s stock, valued at $2,771,600. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Charles P. Hadeed sold 1,358 shares of the company’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total value of $176,540.00. Following the sale, the director now directly owns 21,320 shares of the company’s stock, valued at $2,771,600. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Lee D. Rudow sold 12,000 shares of the stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $135.10, for a total value of $1,621,200.00. Following the completion of the sale, the chief executive officer now directly owns 91,692 shares in the company, valued at $12,387,589.20. The disclosure for this sale can be found here. Insiders have sold a total of 22,215 shares of company stock valued at $2,969,084 over the last ninety days. Company insiders own 4.20% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on Transcat
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Articles
- Five stocks we like better than Transcat
- Investing in large cap stocks: Diving into big caps
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Dividend Capture Strategy: What You Need to Know
- 5 Aggressive Growth Stocks for Long-Term Investors
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Invest Like Congress: 2 ETFs to Add to Your Watchlist
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.